A5011132064- Tuberculosis Research and Epidemiology
- Alcoholism and Thiamine Deficiency
- Biochemical Acid Research Studies
- Pneumocystis jirovecii pneumonia detection and treatment
- Mycobacterium research and diagnosis
- Pleural and Pulmonary Diseases
- Electrolyte and hormonal disorders
- Neurotransmitter Receptor Influence on Behavior
- Neuropeptides and Animal Physiology
- Congenital gastrointestinal and neural anomalies
- Adipokines, Inflammation, and Metabolic Diseases
- Infectious Diseases and Tuberculosis
- Vascular anomalies and interventions
- Lung Cancer Diagnosis and Treatment
- Receptor Mechanisms and Signaling
- Urological Disorders and Treatments
- Diagnosis and treatment of tuberculosis
- Cytokine Signaling Pathways and Interactions
- Sex and Gender in Healthcare
- Bipolar Disorder and Treatment
- Pneumothorax, Barotrauma, Emphysema
Ministry of Education of the People's Republic of China
2023-2024
Huazhong University of Science and Technology
2021-2024
Southeast University
2024
Jinyintan Hospital
2018-2023
Chinese Academy of Medical Sciences & Peking Union Medical College
2023
Academy of Medical Sciences
2023
Wuhan Institute of Virology
2023
Tongji Hospital
2021
To evaluate the clinical efficacy and safety of α-Lipoic acid (ALA) for critically ill patients with coronavirus disease 2019 (COVID-19).A randomized, single-blind, group sequential, active-controlled trial was performed at JinYinTan Hospital, Wuhan, China. Between February 2020 March 2020, 17 COVID-19 were enrolled in our study. Eligible randomly assigned a 1:1 ratio to receive either ALA (1200 mg/d, intravenous infusion) once daily plus standard care or equal volume saline infusion...
Abstract Object To evaluate the clinical efficacy and safety of α-Lipoic acid (ALA) for critically ill patients with coronavirus disease 2019 (COVID-19). Methods A randomized, single-blind, group sequential, active-controlled trial was performed at JinYinTan Hospital, Wuhan, China. Between February 2020 March 2020, 17 COVID-19 were enrolled in our study. Eligible randomly assigned a 1:1 ratio to receive either ALA (1200 mg/d, intravenous infusion) once daily plus standard care or equal...
Objective To investigate if the addition of bedaquiline and clofazimine to a treatment regimen for multidrug-resistant tuberculosis (MDR-TB) could improve patient outcomes. Methods A prospective, randomized, controlled study was conducted in patients with MDR-TB. Treatment 18 months. Patients experimental group received their regular whereas control did not. Results 68 MDR-TB were randomised treatment, 34 each group. At end cure rates statistically significantly greater compared (82% vs....
Anhydrous ethanol, for its part, has been successfully used to treat renal cyst, hepatocellular carcinoma and ovarian chocolate cyst et al. However, in spite of the high frequency tuberculous purulent pleural effusion, we found that only a few very early studies attempted assess use intrapleural anhydrous ethanol effusions with signs empyema. We report patient who was injected into cavity chronic A 23-year old male admitted hospital because Ultra-sonography guided thoracentesis thoracic...
: The periaqueductal gray (PAG) is a central hub for the regulation of aggression, whereas circuitry and molecular mechanisms underlying this remain uncharacterized. In study, we investigate role distinct cell type,
Abstract Background The periaqueductal gray (PAG) is a central hub for regulation of aggression, while little known on the circuitry and molecular mechanisms that govern this regulation. We investigate role distinct cell type, Tachykinin 2 -expressing (Tac2 + ) neurons, located in dorsomedial PAG (dmPAG), modulating aggression mice. Methods combined activity mapping, vivo Ca 2+ recording, chemogenetic pharmacological manipulation, viral-based translating ribosome affinity purification (TRAP)...
Abstract Aim: This study was conducted to determine the impact of patient-centered care (PCC) on treatment adherence and outcome patientswith multidrug- or rifampicin-resistant tuberculosis (MDR/RR-TB). Background: Treatment is critical successful outcomes MDR/RR-TB. However, very few studies published had addressed how improve it. Me thods: retrospectivelyanalyzed MDR/RR-TB patient with two different kinds care: clinical for group A PCC B. Results: There were 128 patients assigned in 155...